Search Results

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, announced that Patrick J. McEnany, Founder, Chairman and CEO of Catalyst, has been bestowed the 2023 Lifetime Achievement Award by BioFlorida at their Annual Meeting last Friday.

Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) (“Coeptis” or “the Company”) today announced that Dan Yerace, Director and Vice President of Operations, will participate in a panel titled, “Ambitious Innovation: Emerging Cell and Gene Therapies,” at the BioFlorida Conference on Thursday October 12th from 11:50 AM-12:50 PM.

ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”) announces that Stephen C. Glover, Co-Founder, Chairman, Chief Executive Officer, and President, will participate in a panel titled, “Understanding Inflammation and the Implications on Diseases,” at the BioFlorida Conference on Thursday October 12th from 10:30-11:30 AM EDT.

Oragenics, Inc., a biotech company dedicated to fighting infectious diseases including COVID-19, announces its participation in the 2022 BioFlorida Annual Conference, being held November 2-4 in Miami.

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, announced that it has been named the “2022 David J. Gury Company of the Year” by BioFlorida.

ZyVersa Therapeutics, Inc. are pleased to announce that Stephen C. Glover, ZyVersa’s Co-Founder, Chief Executive Officer, and Chairman, is an invited speaker at BioFlorida’s 2022 Annual Conference being held in Miami, Florida on November 2-4, 2022.

KemPharm, Inc. today announced that it has been named the 2021 David J. Gury Company of the Year by BioFlorida.

◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.